Moreover, they observed that lncARSR binds to YAP1, a crucial component of the Hippo pathway and a regulator of HCC progression, thus blocking its nuclear translocation while activating IRS2/AKT pathway further to increase lipid accumulation, proliferation, and invasion. The gene discussed is LNCARSR; the disease is hepatocellular carcinoma.